Navigation Links
Phase II study of an oral therapy for Gaucher disease yields positive results
Date:5/3/2010

(WASHINGTON, May 3, 2010) Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.

Gaucher disease is a genetic disorder affecting an estimated 1 in 50,000 to 1 in 100,000 people in the U.S. population. Gaucher disease occurs when a mutation of the glucocerebrosidase gene causes low activity of that enzyme in the body. As a result, harmful fatty substances accumulate in the liver, spleen, bones, and bone marrow, preventing cells and organs from working properly. The primary treatment option is enzyme replacement therapy, which is given intravenously, to break down the accumulated fatty substances.

Eliglustat tartrate is an oral drug currently in development for Gaucher disease type 1 (GD1). As a substrate reduction therapy, the drug decreases the body's production of the fatty substances so they do not accumulate in cells. Based on Phase I trials in healthy volunteers that demonstrated positive initial safety results, the research team initiated a multinational, open-label, single-arm Phase II study of 26 GD1 patients to evaluate the efficacy, safety, and pharmacokinetics (how the body absorbs and processes the drug) of eliglustat tartrate administered orally at 50mg or 100mg doses twice daily. Eligible patients had confirmed Gaucher disease, characterized as enzyme deficiency and a spleen volume at least 10 times greater than normal, plus abnormal values of either platelet count or hemoglobin levels.

"As with many other rare conditions, we strive to develop new options with improved efficacy and safety for our patients, but we also look for options that may be easier on the provider and the patient.In this case, we we
'/>"/>

Contact: Wendy Stokes
webmaster@hematology.org
202-776-0544
American Society of Hematology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New phase II study supports potential of gs-9450 as new treatment option for steatohepatitis
2. Pilot Testing Phase Ends; Expansion Of Sales Force Begins
3. Southampton scientists begin Phase II patient trial for new asthma treatment
4. Intellicate Announces New “Phased Return to Work” (PRtW) Service
5. Askthedoctor.com Makes Medical Information More Accessible to the Public by Completing Phase 1 of US Expansion
6. Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial
7. Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
8. New High Purity Immunoglobulin Enters Phase III in Europe and the US
9. Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements
10. NASA selects DNA Medicine Institutes Nanoscale Diagnostics Technology for Phase II SBIR
11. PRA International Rolls out Client Access to Oracle(R) RDC for Early Phase Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Medelis, Inc., a specialty oncology CRO ... in the role of president. , “ Bill Taaffe ... industry,” said Larry Flanagan, Medelis’ CEO and co-founder. “He will ... next phase of growth.” , Taaffe joined ICON’s U.S. ... employees to over 4,500 employees, achieving 12 consecutive years of ...
(Date:5/28/2015)... May 28, 2015 ISMETT , a ... Italy, boosted the Sicilian economy by €132.5 million in expenditure ... benefit of more than €73 million by retaining patients who ... to a new study by the Battelle Memorial Institute. At ... research, training and advanced health care management that is transforming ...
(Date:5/28/2015)... Trends Investing ” was featured on NewsWatch as part of ... medium, and large businesses making an impact in their industry. ... the business review and shared with viewers how this website ... money. , The idea, “let your money work for you” ... how to succeed are two different things. So if ...
(Date:5/28/2015)... May 28, 2015 Senior Housing Assistance ... Lou Piniella, who managed the Seattle Mariners team that ... will appear in television and digital advertising for SHAG ... apartment communities, including several new communities slated to open ... Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. , ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Ticket Down is ... soccer match between Mexico and Argentina in early ... the world will compete on the pitch at AT&T Stadium ... another in an international friendly on Tuesday, September 8th at ... talented nations in the world including some of the most ...
Breaking Medicine News(10 mins):Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3
... 11 Oridion,Systems, Ltd. - (SWX: ORIDN) ... improving patient safety. This new launch ... of,Anesthesiologists in San Francisco, CA. Smart ... its new SARA(TM) software for improved alarm ...
... the first,time in Pennsylvania, Level III Trauma Center accreditation status ... 1, 2007 through,October 31, 2008:, ... Good Samaritan Regional Medical Center, Pottsville, PA, ... by the Emergency Medical Services Act (Act 1985-45).,The PTSF is ...
... * concentrated Tylenol(R) Infants, Drops Plus Cold and cough ... * PediaCare(R) Infant Drops products, ... of McNeil-PPC, Inc., announced today that the,company is voluntarily withdrawing certain ... these medicines are generally,recognized as safe and effective. While most parents ...
... scrapbooking service to help ... MIAMI, Oct. 11 Scrapblog, Inc., the first web-based,service ... partnering with the March of Dimes, a national not-for-profit health,agency ... ,Every,Baby Has a Story, campaign. ,Every Baby Has a ...
... retirees will benefit, SACRAMENTO, Calif., Oct. 10 ... California State University (CSU) retirees to,participate in a ... very grateful that the Legislature and governor have ... all state retirees," said,Barbara LaPlante, President of CSEA ...
... Molina Healthcare Inc. (NYSE: MOH ),will replace Keystone Automotive ... after the close of trading on Friday, October 12. Keystone ... LKQX ) in,a deal that is expected to close ... Poor,s will monitor this transaction, and post any relevant,updates on ...
Cached Medicine News:Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 3Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 4Health News:First Level III Trauma Center Accredited in Pennsylvania 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 3Health News:Scrapblog(TM) Teams with March of Dimes to Tell Every Baby's Story 2Health News:Scrapblog(TM) Teams with March of Dimes to Tell Every Baby's Story 3Health News:Governor Signs Bill Providing Vision Care Program for State University Retirees 2Health News:Standard & Poor's Announces Change to U.S. Index 2
(Date:5/28/2015)... CHICAGO , May 28, 2015  It takes ... gift to help break the cycle of hunger and ... May 28, by announcing that its recent donation to ... Africa Dairy Development Project (EADD) in Tanzania ... Heifer,s EADD Project, and perhaps changing their lives forever. ...
(Date:5/28/2015)... 28, 2015 Lungpacer Medical, Inc., a ... system announced today that it will be presenting ... Thursday, June 4, 2015 in New York City.  ... Eastern Time.   About Lungpacer Medical, ... stage medical device company pioneering the development of ...
(Date:5/28/2015)... , May 28, 2015  Oticon, Inc. is ... People Awards. The national awards program, now in its ... with hearing loss who demonstrate that hearing loss does ... excel. People with any degree of ... are eligible. Winners in four categories earn cash prizes, ...
Breaking Medicine Technology:AbelsonTaylor Honors World Hunger Day 22015 Oticon Focus on People Awards Seek Outstanding People with Hearing Loss For National Recognition and Prizes 2
... 2012  IMCAS -- Merz Aesthetics today releases further intriguing insights uncovered ... our out of five surveyed European women think that ... dermal fillers, botulinum toxins, and laser treatments to maintain their ... for the super-rich or Hollywood elite, two thirds of the ...
... (NASDAQ: MASI ) announced today that it will ... ended December 31, 2011, after the market closes on February 14, ... 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by ... Raad, Executive Vice President and Chief Financial Officer. A ...
Cached Medicine Technology:The Changing Face of Beauty 2The Changing Face of Beauty 3The Changing Face of Beauty 4The Changing Face of Beauty 5Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 2Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 3
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
ELP 40- 8 Way Head Strip Plate Washer....
Finstruments 96 well washer and Cellwasher. Multi-function with touch programmable display....
The Finstrip 4 is an effective and reliable microplate washer offering high performance, simplicity and ease of use....
Medicine Products: